Julien Geffrelot
Papers
1
Total Citations
25
H-Index
1
About
Dr. Julien Geffrelot is a leading radiation oncologist whose research focuses on stereotactic radiotherapy for intracranial tumors, particularly meningiomas. His major contribution lies in demonstrating the efficacy and safety of hypofractionated stereotactic radiotherapy (hFSRT) for patients with intracranial meningiomas, a common type of brain tumor. In his most cited work (25 citations), he evaluated a large cohort of 126 patients treated with robotic hFSRT between 2008 and 2016, providing robust evidence that this regimen achieves excellent local control while minimizing toxicity. This study has helped establish hFSRT as a viable treatment option, offering a shorter, more convenient alternative to conventional fractionated radiotherapy without compromising outcomes. Dr. Geffrelot’s work has significantly advanced the clinical management of meningiomas, impacting treatment guidelines and patient care. His research continues to shape the field of stereotactic radiation oncology, making him a respected voice in neuro-oncology.
Research Focus
Key Achievements
Top Papers
- 1